Integrated Quantitative Investments’s Fortress Biotech FBIO Stock Holding History

Integrated Quantitative Investments’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$210K	Buy	+68,692	New	+$177K	0.03%	367

Other funds holding FBIO

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

SAM

Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Integrated Quantitative Investments's FBIO Position: Q2 2026 in Review

Integrated Quantitative Investments opened a new position in Fortress Biotech (FBIO) in Q2 2026: 68,692 shares worth $210K. The stake represents 0.03% of the portfolio and ranks #367 among its holdings.

55 funds tracked by Wall St. Rank hold FBIO as of Q2 2026.

Integrated Quantitative Investments held 68,692 shares of Fortress Biotech worth $210K as of Q2 2026.
Fortress Biotech was a new Integrated Quantitative Investments position in Q2 2026.
Fortress Biotech made up 0.03% of Integrated Quantitative Investments's portfolio in Q2 2026, its #367 holding.
55 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2026.

Based on Integrated Quantitative Investments's 13F filing for Q2 2026, filed 14 Aug 2026.